These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19414679)

  • 1. Genome-wide analysis of survival in early-stage non-small-cell lung cancer.
    Huang YT; Heist RS; Chirieac LR; Lin X; Skaug V; Zienolddiny S; Haugen A; Wu MC; Wang Z; Su L; Asomaning K; Christiani DC
    J Clin Oncol; 2009 Jun; 27(16):2660-7. PubMed ID: 19414679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
    Li B; Cui Y; Diehn M; Li R
    JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancer.
    Lee SY; Choi JE; Jeon HS; Hong MJ; Choi YY; Kang HG; Yoo SS; Lee EB; Jeong JY; Lee WK; Lee J; Cha SI; Kim CH; Kim YT; Jheon S; Son JW; Park JY
    Ann Oncol; 2015 Jun; 26(6):1142-1148. PubMed ID: 25716425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of high expression levels of STK39 in the growth, migration and invasion of non-small cell type lung cancer cells.
    Li Z; Zhu W; Xiong L; Yu X; Chen X; Lin Q
    Oncotarget; 2016 Sep; 7(38):61366-61377. PubMed ID: 27542260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
    Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
    Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prognostic DNA methylation signature for stage I non-small-cell lung cancer.
    Sandoval J; Mendez-Gonzalez J; Nadal E; Chen G; Carmona FJ; Sayols S; Moran S; Heyn H; Vizoso M; Gomez A; Sanchez-Cespedes M; Assenov Y; Müller F; Bock C; Taron M; Mora J; Muscarella LA; Liloglou T; Davies M; Pollan M; Pajares MJ; Torre W; Montuenga LM; Brambilla E; Field JK; Roz L; Lo Iacono M; Scagliotti GV; Rosell R; Beer DG; Esteller M
    J Clin Oncol; 2013 Nov; 31(32):4140-7. PubMed ID: 24081945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.
    Wu X; Ye Y; Rosell R; Amos CI; Stewart DJ; Hildebrandt MA; Roth JA; Minna JD; Gu J; Lin J; Buch SC; Nukui T; Ramirez Serrano JL; Taron M; Cassidy A; Lu C; Chang JY; Lippman SM; Hong WK; Spitz MR; Romkes M; Yang P
    J Natl Cancer Inst; 2011 May; 103(10):817-25. PubMed ID: 21483023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants of the Wnt signaling pathway as predictors of recurrence and survival in early-stage non-small cell lung cancer patients.
    Coscio A; Chang DW; Roth JA; Ye Y; Gu J; Yang P; Wu X
    Carcinogenesis; 2014 Jun; 35(6):1284-91. PubMed ID: 24517998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
    Yoon KA; Yoon H; Park S; Jang HJ; Zo JI; Lee HS; Lee JS
    J Thorac Cardiovasc Surg; 2012 Oct; 144(4):794-807. PubMed ID: 22818121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of polymorphic variations in the 5p15, 6p12, 6p21 and 15q25 Loci on the risk and prognosis of portuguese patients with non-small cell lung cancer.
    de Mello RA; Ferreira M; Soares-Pires F; Costa S; Cunha J; Oliveira P; Hespanhol V; Reis RM
    PLoS One; 2013; 8(9):e72373. PubMed ID: 24039754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
    Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
    Lee Y; Yoon KA; Joo J; Lee D; Bae K; Han JY; Lee JS
    Carcinogenesis; 2013 Feb; 34(2):307-13. PubMed ID: 23144319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exome-Wide Association Study Identifies Low-Frequency Coding Variants in 2p23.2 and 7p11.2 Associated with Survival of Non-Small Cell Lung Cancer Patients.
    Zhu M; Geng L; Shen W; Wang Y; Liu J; Cheng Y; Wang C; Dai J; Jin G; Hu Z; Ma H; Shen H
    J Thorac Oncol; 2017 Apr; 12(4):644-656. PubMed ID: 28104536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genetic sequence variant (GSV) at susceptibility loci of 5p15.33 (TERT-CLPTM1L) is associated with survival outcome in locally advanced and metastatic non-small-cell lung cancer (NSCLC).
    Azad AK; Qiu X; Boyd K; Kuang Q; Emami M; Perera N; Palepu P; Patel D; Chen Z; Cheng D; Feld R; Leighl NB; Shepherd FA; Tsao MS; Xu W; Liu G; Cuffe S
    Lung Cancer; 2014 Jun; 84(3):289-94. PubMed ID: 24679952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
    Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
    Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.
    Gentles AJ; Bratman SV; Lee LJ; Harris JP; Feng W; Nair RV; Shultz DB; Nair VS; Hoang CD; West RB; Plevritis SK; Alizadeh AA; Diehn M
    J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26286589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
    Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer.
    Chen DT; Hsu YL; Fulp WJ; Coppola D; Haura EB; Yeatman TJ; Cress WD
    J Natl Cancer Inst; 2011 Dec; 103(24):1859-70. PubMed ID: 22157961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies.
    Kratz JR; He J; Van Den Eeden SK; Zhu ZH; Gao W; Pham PT; Mulvihill MS; Ziaei F; Zhang H; Su B; Zhi X; Quesenberry CP; Habel LA; Deng Q; Wang Z; Zhou J; Li H; Huang MC; Yeh CC; Segal MR; Ray MR; Jones KD; Raz DJ; Xu Z; Jahan TM; Berryman D; He B; Mann MJ; Jablons DM
    Lancet; 2012 Mar; 379(9818):823-32. PubMed ID: 22285053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Predictive 7-Gene Assay and Prognostic Protein Biomarkers for Non-small Cell Lung Cancer.
    Guo NL; Dowlati A; Raese RA; Dong C; Chen G; Beer DG; Shaffer J; Singh S; Bokhary U; Liu L; Howington J; Hensing T; Qian Y
    EBioMedicine; 2018 Jun; 32():102-110. PubMed ID: 29861409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.